<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01814657</url>
  </required_header>
  <id_info>
    <org_study_id>00029750</org_study_id>
    <nct_id>NCT01814657</nct_id>
  </id_info>
  <brief_title>Optimizing Patient Analgesic Experience During IVF</brief_title>
  <official_title>Optimizing Patient Analgesic Experience During IVF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is for patients undergoing In Vitro Fertilization (IVF). The investigators are&#xD;
      studying the best way to control pain during the egg retrieval process. The egg retrieval&#xD;
      involves passing a needle under ultrasound guidance through the vagina into the ovaries to&#xD;
      remove eggs that are to be later fertilized. Patients often report this as very&#xD;
      uncomfortable.&#xD;
&#xD;
      Different fertility clinics across the country use different methods of pain control. All&#xD;
      clinics will use intravenous medication to control pain, while some may or may not use local&#xD;
      anaesthetic (freezing) in the vagina. Our goal is to find the best way to control pain. Since&#xD;
      local anaesthetic injection involves multiple needle punctures and may be painful, the&#xD;
      investigators are unsure if local anaesthetic is necessary in addition to the intravenous&#xD;
      pain medication.&#xD;
&#xD;
      The investigators will conduct a randomized trial where all patients will receive intravenous&#xD;
      pain medication, but some will receive local anaesthetic injection and some will receive&#xD;
      placebo injection. Patients will be asked to complete a questionnaire on their pain&#xD;
      experience after oocyte retrieval. The investigators will then analyze the data and determine&#xD;
      whether local anaesthetic actually improves pain when patients are already receiving&#xD;
      intravenous pain medications. Through our study, the investigators aim to improve the pain&#xD;
      experience of all women undergoing IVF in the future.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
      A UK telephone survey (Bokhari, 1999) showed that during TUGOR, 48% of UK fertility centers&#xD;
      were using conscious sedation, 29% general anaesthesia, 12% conscious sedation with regional&#xD;
      anaesthesia (neuraxial block or PCB), and 2% regional anaesthesia alone. A review article&#xD;
      (Blahos 2009) details the many different types of anaesthesia used during TUGOR. These may&#xD;
      include combinations of the following: general anaesthesia, regional anaesthesia, local&#xD;
      anaesthesia, conscious sedation, and alternative methods of anaesthesia (electro-acupuncture,&#xD;
      patient controlled sedation). No recent studies were found detailing the frequency of each of&#xD;
      the various anaesthetic options in use at fertility centers across North American.&#xD;
&#xD;
      A prospective, randomized, double-blind and placebo controlled study (Ng, 1999) showed that&#xD;
      paracervical block combined with conscious sedation was superior to conscious sedation alone.&#xD;
      This study used a combination of drugs (mepiridine and diazepam) not used at our center. The&#xD;
      use of fentanyl and midazolam was first described by Harrison in 1992 for conscious sedation.&#xD;
      In 2001 Sephton et al published a cross over audit of patient preferences comparing&#xD;
      mepiridine, diazepam and promethazine to fentanyl and midazolam, showing superiority of&#xD;
      fentanyl and midazolam. Midazolam has sedative and amnestic properties, whereas diazepam has&#xD;
      no amnestic properties. The amnestic properties of midazolam make it a superior medication&#xD;
      for overall patient experience during TUGOR, as they are less likely to recall potentially&#xD;
      painful parts of their procedure. Midazolam has also been shown to act synergistically with&#xD;
      fentanyl, thereby decreasing not only the actual pain recalled, but the actual pain&#xD;
      experienced by patients. Since the only randomized control trial demonstrating the benefits&#xD;
      of paracervical block was performed using mepiridine and diazepam, we intend to repeat the&#xD;
      study using the superior combination of fentanyl and midazolam.&#xD;
&#xD;
      Study Rationale:&#xD;
&#xD;
      The oocyte retrieval may be the most painful part of fertility treatment. Our goal is to&#xD;
      minimize patient discomfort and improve overall patient experience during fertility&#xD;
      treatments. We do not know if PCB improves pain scores in the era of wider use of fentanyl&#xD;
      and midazolam for sedation. Fertility centres may be subjecting their patients to a painful&#xD;
      PCB injection without proven benefit. This study aims to assess whether a PCB in addition to&#xD;
      conscious sedation can be abandoned without impacting the patient's overall pain experience.&#xD;
&#xD;
      Study Objective:&#xD;
&#xD;
      The objective is to compare whether conscious sedation alone is as effective as paracervical&#xD;
      block plus conscious sedation in controlling pain during oocyte retrieval&#xD;
&#xD;
      Study Question:&#xD;
&#xD;
      Is conscious sedation alone as effective as paracervical block plus conscious sedation in&#xD;
      controlling pain during oocyte retrieval?&#xD;
&#xD;
      Overview of the Trial Design This study is designed to be a placebo-controlled, randomised,&#xD;
      double blind trial to compare whether conscious sedation with a normal saline paracervical&#xD;
      block (placebo) is as effective as conscious sedation with a lidocaine paracervical block in&#xD;
      controlling pain during oocyte retrieval. A total of 300 women will randomly be assigned in a&#xD;
      1:1 ratio, after consenting to study participation. Short-Form McGill Pain scores will be&#xD;
      assessed in study subjects.&#xD;
&#xD;
      Study Population:&#xD;
&#xD;
      Women presenting for oocyte retrieval after a cycle of IVF stimulation at the University of&#xD;
      Alberta Regional Fertility Centre&#xD;
&#xD;
      Study Design:&#xD;
&#xD;
      Women consenting to participate in the study will be randomly allocated to one of two groups.&#xD;
      The control group will receive conscious sedation with a placebo (normal saline) paracervical&#xD;
      block (PCB). The study group will receive conscious sedation with a local anaesthetic&#xD;
      (lidocaine 1%) PCB. Computer generated randomisation will be used to determine group&#xD;
      allocation. Group allocation will be concealed using opaque envelopes to ensure blinding. An&#xD;
      OR nurse will prepare the PCB syringe with either lidocaine or normal saline depending on the&#xD;
      patient's allocation. The contents of the PCB will remain blinded from the physician&#xD;
      performing the TUGOR and the patient.&#xD;
&#xD;
      The fertility centre's routine for TUGOR is as follows: Initially conscious sedation is&#xD;
      administered by OR nursing staff according to the patient's weight (midazolam 1 - 2 mg and&#xD;
      fentanyl 50 - 75 ug IV). This is followed by the PCB 5 minutes later. Additional fentanyl is&#xD;
      administered throughout the procedure as required to ensure patient comfort. The oocyte&#xD;
      retrieval proceeds once the PCB is completed. Following the oocyte retrieval and when the&#xD;
      conscious sedation has worn off; the patient will be assessed before discharge. Once the&#xD;
      discharge criteria have been met, the validated and standardized Short-Form McGill Pain&#xD;
      Questionnaire will be used to objectively measure the pain experienced during the TUGOR. All&#xD;
      study participants will be required to rate the pain experience during the procedure. The&#xD;
      attending nurse is required to record all adverse events from the procedure as part of her&#xD;
      clinical duties. Embryology information, i.e. fertilization, embryo grading, development and&#xD;
      frozen rates will be recorded to assess whether PCB affects this aspect of ART. Additional&#xD;
      information will be obtained by reviewing participants' clinic charts nine months&#xD;
      post-procedure to determine secondary outcomes, i.e. live birth rates. Animal mouse models in&#xD;
      the past have shown local anaesthetic to adversely affect fertilization and embryo&#xD;
      development (Schnell, 1992). No adverse effects on human embryos from lidocaine have ever&#xD;
      been demonstrated (Wikland 1990), however assessing embryo quality and birth outcomes has&#xD;
      been the standard when conducting studies assessing the use of PCB&#xD;
&#xD;
      Setting:&#xD;
&#xD;
      Academic referral fertility centre&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores rated on SF-MPQ</measure>
    <time_frame>Data collection is scheduled to proceed until 308 participants have been recruited which is anticipated to take up to 2 years.</time_frame>
    <description>Score rating will be done before the patient is discharged following oocyte retrieval.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Embryology data</measure>
    <time_frame>Assessed within 7 days of oocyte retrieval</time_frame>
    <description>Recorded as number of embryos obtained. Number of embryos transferred. The decision to transfer Day 3 embryos or Day 5 blastocysts. Number of embryos or blastocysts frozen. Embryological grading of all embryos or blastocysts either transferred or frozen.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Live Birth Rates</measure>
    <time_frame>Within 12 months of oocyte retrieval</time_frame>
    <description>Recorded as the number of infants born alive to the patient that resulted from embryos transferred during this study.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">308</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Conscious sedation and sterile normal saline (placebo) paracervical block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conscious sedation and Lidocaine hydrochloride 1% solution paracervical block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine hydrochloride (HCl) 1% solution</intervention_name>
    <description>Comparison of paracervical block using Lidocaine versus Normal Saline placebo in patients undergoing oocyte retrieval during IVF.</description>
    <arm_group_label>Lidocaine</arm_group_label>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sterile Normal Saline%</intervention_name>
    <description>Sterile normal saline used as placebo for lidocaine hydrochloride (HCl)1% solution</description>
    <arm_group_label>Normal Saline</arm_group_label>
    <other_name>Sterile Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women undergoing oocyte retrieval who have consented to participation&#xD;
&#xD;
          -  Only the first ART cycle will be included&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of drug sensitivity to local anaesthetic agents&#xD;
&#xD;
          -  Women with any chronic pain syndrome&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tarek Motan, MB ChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fertility and Womens Endocrine Clinic</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5H 3V9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarek Motan, MB ChB</last_name>
      <phone>780-735-5604</phone>
    </contact>
    <investigator>
      <last_name>Tarek Motan, MB ChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tom Gotz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Ng EH, Tang OS, Chui DK, Ho PC. A prospective, randomized, double-blind and placebo-controlled study to assess the efficacy of paracervical block in the pain relief during egg collection in IVF. Hum Reprod. 1999 Nov;14(11):2783-7.</citation>
    <PMID>10548622</PMID>
  </reference>
  <reference>
    <citation>Bhattacharya S, MacLennan F, Hamilton MP, Templeton A. How effective is patient-controlled analgesia? A randomized comparison of two protocols for pain relief during oocyte recovery. Hum Reprod. 1997 Jul;12(7):1440-2.</citation>
    <PMID>9262274</PMID>
  </reference>
  <reference>
    <citation>Elkington NM, Kehoe J, Acharya U. Intravenous sedation in assisted conception units: a UK survey. Hum Fertil (Camb). 2003 May;6(2):74-6.</citation>
    <PMID>12869788</PMID>
  </reference>
  <reference>
    <citation>Bokhari A, Pollard BJ. Anaesthesia for assisted conception: a survey of UK practice. Eur J Anaesthesiol. 1999 Apr;16(4):225-30.</citation>
    <PMID>10234491</PMID>
  </reference>
  <reference>
    <citation>Vlahos NF, Giannakikou I, Vlachos A, Vitoratos N. Analgesia and anesthesia for assisted reproductive technologies. Int J Gynaecol Obstet. 2009 Jun;105(3):201-5. doi: 10.1016/j.ijgo.2009.01.017. Epub 2009 Feb 26. Review.</citation>
    <PMID>19249049</PMID>
  </reference>
  <reference>
    <citation>Sephton VC, Shaw A, Cowan CM, Thomas K, Wood S, Barclay PM, Kingsland CR. Sedation and analgesia for transvaginal oocyte retrieval: an audit resulting in a change of clinical practice. Hum Fertil (Camb). 2001;4(2):94-8.</citation>
    <PMID>11591263</PMID>
  </reference>
  <reference>
    <citation>Harrison RF, Barry-Kinsella C, Drudy L, Gordon A, Hannon K, Hennelly B, Keogh I, Kondaveeti U, Nargund G, Verso J. An Irish out-patient based in-vitro fertilisation service. Ir Med J. 1992 Jun;85(2):63-5.</citation>
    <PMID>1628945</PMID>
  </reference>
  <reference>
    <citation>Gohar J, Lunenfeld E, Potashnik G, Glezerman M. The use of sedation only during oocyte retrieval for in vitro fertilization: patients' pain self-assessments versus doctors' evaluations. J Assist Reprod Genet. 1993 Oct;10(7):476-8.</citation>
    <PMID>8069089</PMID>
  </reference>
  <reference>
    <citation>Wikland M, Evers H, Jakobsson AH, Sandqvist U, Sj√∂blom P. The concentration of lidocaine in follicular fluid when used for paracervical block in a human IVF-ET programme. Hum Reprod. 1990 Nov;5(8):920-3.</citation>
    <PMID>2081803</PMID>
  </reference>
  <reference>
    <citation>Schnell VL, Sacco AG, Savoy-Moore RT, Ataya KM, Moghissi KS. Effects of oocyte exposure to local anesthetics on in vitro fertilization and embryo development in the mouse. Reprod Toxicol. 1992;6(4):323-7.</citation>
    <PMID>1521005</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <study_first_submitted>March 8, 2013</study_first_submitted>
  <study_first_submitted_qc>March 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2013</study_first_posted>
  <last_update_submitted>December 31, 2014</last_update_submitted>
  <last_update_submitted_qc>December 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alberta</investigator_affiliation>
    <investigator_full_name>Tarek Motan</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Infertility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

